Product
prednisone/prednisolone
1 clinical trial
1 indication
Indication
Hodgkin lymphomaClinical trial
An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma With Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)Status: Active (not recruiting), Estimated PCD: 2027-02-13